These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 407303)
1. Receptors for C3 on rat peritoneal mast cells. Sher A; McIntyre SL J Immunol; 1977 Aug; 119(2):722-5. PubMed ID: 407303 [TBL] [Abstract][Full Text] [Related]
2. Light and electron microscopic appearance of rat peritoneal mast cells adhering to schistosomula of Schistosoma mansoni by means of complement or antibody. Caulfield JP; Hein A; Moser G; Sher A J Parasitol; 1981 Dec; 67(6):776-83. PubMed ID: 7328450 [TBL] [Abstract][Full Text] [Related]
3. [Receptors for complement on rat mast cells and release of histamine]. Schnitzler S; Renner H; Lange R; Vogt I Acta Biol Med Ger; 1978; 37(10):1531-5. PubMed ID: 88140 [TBL] [Abstract][Full Text] [Related]
4. Complement-independent adherence of Escherichia coli to complement receptors in vitro. Fine DP; Harper BL; Carpenter ED; Davis CP; Cavallo T; Guckian JC J Clin Invest; 1980 Sep; 66(3):465-72. PubMed ID: 6105165 [TBL] [Abstract][Full Text] [Related]
5. Adherence of monocytes and polymorphonuclear cells to infective larvae of Strongyloides stercoralis after complement activation. de Messias IJ; Genta RM; Mohren WD J Parasitol; 1994 Apr; 80(2):267-74. PubMed ID: 8158470 [TBL] [Abstract][Full Text] [Related]
6. Complement-mediated leukocyte adherence to infective larvae of Dipetalonema viteae (Filarioidea): requirement for eosinophils or eosinophil products in effecting macrophage adherence. Haque A; Ouaissi A; Santoro F; des Moutis I; Capron A J Immunol; 1982 Nov; 129(5):2219-25. PubMed ID: 6889619 [TBL] [Abstract][Full Text] [Related]
7. In vitro killing of S. mansoni schistosomula by eosinophils from infected rats: role of cytophilic antibodies. Capron M; Torpier G; Capron A J Immunol; 1979 Nov; 123(5):2220-30. PubMed ID: 489980 [TBL] [Abstract][Full Text] [Related]
8. Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation. Santoro F; Lachmann PJ; Capron A; Capron M J Immunol; 1979 Oct; 123(4):1551-7. PubMed ID: 113459 [TBL] [Abstract][Full Text] [Related]
9. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. Schreiber AD; Frank MM J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104 [TBL] [Abstract][Full Text] [Related]
11. Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomula. Capron M; Rousseaux J; Mazingue C; Bazin H; Capron A J Immunol; 1978 Dec; 121(6):2518-25. PubMed ID: 722083 [TBL] [Abstract][Full Text] [Related]
12. Phagocytosis by rat peritoneal mast cells: independence of IgG Fc-mediated and C3-mediated signals. Otani I; Conrad DH; Carlo JR; Segal DM; Ruddy S J Immunol; 1982 Nov; 129(5):2109-12. PubMed ID: 6214589 [TBL] [Abstract][Full Text] [Related]
13. Plasma therapy of primary rat mammary carcinoma: dependence of consumption of C3 during absorption of plasma with sepharose derivatives on the anticoagulant. Nakanishi K; Zbar B; Borsos T Cancer Res; 1985 Sep; 45(9):4122-7. PubMed ID: 3928150 [TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum. Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484 [No Abstract] [Full Text] [Related]
15. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. IV. Analysis of the role of IgE antibodies and mast cells. Sher A; Correa-Oliveira R; Hieny S; Hussain R J Immunol; 1983 Sep; 131(3):1460-5. PubMed ID: 6193190 [TBL] [Abstract][Full Text] [Related]
16. Complement-mediated killing of schistosomula of Schistosoma mansoni by rat eosinophils in vitro. Ramalho-Pinto FJ; McLaren DJ; Smithers SR J Exp Med; 1978 Jan; 147(1):147-56. PubMed ID: 627834 [TBL] [Abstract][Full Text] [Related]
17. Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides. Anwar AR; McKean JR; Smithers SR; Kay AB J Immunol; 1980 Mar; 124(3):1122-9. PubMed ID: 7358978 [No Abstract] [Full Text] [Related]
18. Studies of the alternate pathway in chelated serum. Forsgren A; Mclean RH; Michael AF; Quie PG J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816 [TBL] [Abstract][Full Text] [Related]
19. Evidence for IgE-dependent cytotoxicity by rat eosinophils. Capron M; Bazin H; Joseph M; Capron A J Immunol; 1981 May; 126(5):1764-8. PubMed ID: 7217664 [TBL] [Abstract][Full Text] [Related]
20. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway. Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]